Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline nasal spray for post-tonsillectomy symptoms in children
IRCT20110528006617N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxymetazoline in tonsillar disease (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Cough, Sore throat and 1 more. Started Sep 2022; status: completed.
02
Drugs
oxymetazoline
03
Conditions
tonsillar disease
Beyond the preview
Go deeper on IRCT20110528006617N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110528006617N7.